← All Investors
BIOXCEL THERAPEUTICS INC
BTAI
Holders
2
Combined Value
$2.9M
Combined Shares
2,177,948
Current Price
$1.19
52W High
$8.08
vs 52W High
−85.3%
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Israel Englander - Millennium Management | $2.6M | 0.00% | ~$2.10 | −43.2% | Bought Q1 2026 | Q1 2026 |
| Howard Marks - Oaktree Capital | $323K | 0.01% | ~$1.81 | −34.3% | Bought Q2 2025 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Israel Englander - Millennium Management | BUY | +$136K | ~$1.34 |
| Q4 2025 | Israel Englander - Millennium Management | BUY | +$1.3M | ~$1.60 |
| Q3 2025 | Israel Englander - Millennium Management | NEW BUY | +$2.6M | ~$2.56 |
| Q3 2025 | Ken Griffin - Citadel Advisors | SOLD OUT | −$20K | ~$1.81 |
| Q2 2025 | Howard Marks - Oaktree Capital | NEW BUY | +$436K | ~$1.81 |
| Q2 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$20K | ~$1.81 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 2 | 2,177,948 | +4.9% | $2.9M | $1.34 |
| Q4 2025 | 2 | 2,076,380 | +63.6% | $3.3M | $1.60 |
| Q3 2025 | 2 | 1,269,241 | +402.5% | $3.2M | $2.56 |
| Q2 2025 | 2 | 252,566 | — | $457K | $1.81 |